Adverse reactions of antirheumatic drugs.
D000700:Analgesics / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D002738:Chloroquine / Q000009:adverse effects; D004123:Dimethylamines / Q000009:adverse effects; D004342:Drug Hypersensitivity; D006046:Gold / Q000009:adverse effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007213:Indomethacin / Q000009:adverse effects / Q000494:pharmacology; D008314:Malonates / Q000009:adverse effects; D008528:Mefenamic Acid / Q000009:adverse effects; D010396:Penicillamine / Q000009:adverse effects; D011422:Propionates / Q000009:adverse effects; D011448:Prostaglandin Antagonists; D011720:Pyrazoles / Q000009:adverse effects; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012459:Salicylates / Q000009:adverse effects / Q000494:pharmacology; D013256:Steroids / Q000009:adverse effects; D014227:Triazines / Q000009:adverse effects
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D004123:Dimethylamines; D007166:Immunosuppressive Agents; D008314:Malonates; D011422:Propionates; D011448:Prostaglandin Antagonists; D011720:Pyrazoles; D012459:Salicylates; D013256:Steroids; D014227:Triazines; D008528:Mefenamic Acid; D006046:Gold; D002738:Chloroquine; D010396:Penicillamine; D007213:Indomethacin